TALLADEGA, Ala. – After years of legal challenges, delays, and administrative disputes, Alabama’s long-stalled medical marijuana program is finally taking a concrete step forward with Callie’s Apothecary in Montgomery opening on May 4, 2026, and other dispensaries expected to open soon, including one in Talladega and another in neighboring Oxford.
The Alabama Medical Cannabis Commission has voted to award dispensary licenses to four companies, each authorized to operate up to three locations, setting the stage for a total of 12 dispensaries across the state. The four approved dispensary license holders are GP6 Wellness LLC, RJK Holdings LLC, CCS of Alabama LLC, and Yellowhammer Medical Dispensaries LLC.
One license, issued to Yellowhammer Medical Dispensaries, is currently subject to a temporary stay. The commission is scheduled to revisit that issue later this month as part of a separate challenge filed by Capitol Medical LLC.
Physicians who have completed the required state training course have begun submitting certification applications. Alabama law allows medical marijuana to be recommended for a defined list of conditions, including cancer-related pain, epilepsy, PTSD, Parkinson’s disease, sickle cell disease, terminal illnesses, and certain cases of chronic pain where conventional treatments have failed.
Products sold at dispensaries will be limited to non-smokable forms, including tablets, capsules, tinctures, topical oils and creams, transdermal patches, suppositories, and inhaler-based liquids. Raw flower, vape products, and marijuana-infused foods such as candies or baked goods will remain prohibited under state law.
